<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01493102</url>
  </required_header>
  <id_info>
    <org_study_id>2011-09-007</org_study_id>
    <nct_id>NCT01493102</nct_id>
  </id_info>
  <brief_title>Discontinuation Order of Vasopressors in Septic Shock</brief_title>
  <acronym>DOVSS</acronym>
  <official_title>Incidence of Hypotension Based on the Discontinuation Order of Vasopressors in the Management of Septic Shock</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the incidence of hypotension based on the
      discontinuation order of norepinephrine and vasopressin in patients receiving concomitant
      norepinephrine and vasopressin infusions for the treatment of septic shock.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There are little data regarding the discontinuation of vasopressors in patients with septic
      shock. Therefore, the investigators intend to evaluate the incidence of hypotension based on
      the discontinuation order of norepinephrine and vasopressin in patients receiving concomitant
      norepinephrine and vasopressin infusions for the treatment of septic shock.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Futility by interim analysis
  </why_stopped>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of hypotension</measure>
    <time_frame>One hour after dose reduction of vasopressors</time_frame>
    <description>Hypotension is defined as mean arterial pressure is less than 65mmHg</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time of hypotension</measure>
    <time_frame>One hour after dose reduction of vasopressors</time_frame>
    <description>Time interval (min) from time of dose reduction of vasopressors to time to development of hypotension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vasopressor free day</measure>
    <time_frame>28 days after dose reduction of vasopressors</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>28-day mortality</measure>
    <time_frame>28 days</time_frame>
    <description>All cause mortality within 28 days after hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU mortality</measure>
    <time_frame>3 months</time_frame>
    <description>All cause mortlity during ICU admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital mortality</measure>
    <time_frame>3 months</time_frame>
    <description>All cause mortality during hospitalization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">78</enrollment>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>Vasopressin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vasopressin will be reduced first (0.01 U/hour)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Norepinephrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Norepinephrine: Norepinephrine will be reduced first (0.1 microgram/kg/hour)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vasopressin</intervention_name>
    <description>Vasopressin will be reduced first (0.01 U/hour)</description>
    <arm_group_label>Vasopressin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Norepinephrine</intervention_name>
    <description>Norepinephrine will be reduced first (0.1 microgram/kg/hour)</description>
    <arm_group_label>Norepinephrine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients 20 years of age or older

          -  patients of receiving concomitant therapy with norepinephrine and vasopressin for teh
             management of septic shock

          -  patients began to reduce the vasopressor

        Exclusion Criteria:

          -  patients who expired or had care withdrawn while receiving norepinephrine and
             vasopressin

          -  patients being transferred into the ICU from an outside facility or the operating room

          -  patients who are suspected to have vasopressin deficiency (eg. HPA axis dysfunction,
             empty sella)

          -  acute myocardial infarction or Congestive heart failure (NYHA functional
             classification III or IV)

          -  acute mesenteric ischemia

          -  patients who were received other vasopressor except for norepinephrine or vasopressin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>kyeongman Jeon, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2011</study_first_submitted>
  <study_first_submitted_qc>December 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2011</study_first_posted>
  <last_update_submitted>January 28, 2015</last_update_submitted>
  <last_update_submitted_qc>January 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>Kyeongman Jeon</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>septic shock</keyword>
  <keyword>norepinephrine</keyword>
  <keyword>vasopressin</keyword>
  <keyword>hypotension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Norepinephrine</mesh_term>
    <mesh_term>Vasopressins</mesh_term>
    <mesh_term>Arginine Vasopressin</mesh_term>
    <mesh_term>Vasoconstrictor Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

